Volpara Health TechnologiesのIPO年
Volpara Health TechnologiesのIPO年は何ですか。
Volpara Health Technologies LimitedのIPO年は2016です。
IPO年の定義は何ですか。
新規公開株 (IPO)は、企業の株式を通常は機関投資家に販売し、順番に証券取引所で一般市民に販売する株式公開の一種です。
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
ASXのセクタHealth CareにおけるIPO年の企業と比べるVolpara Health Technologies
Volpara Health Technologiesは何をしますか。
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry worldwide. The company offers Volpara Analytics software, a cloud-based breast imaging analytics platform that delivers performance monitoring solutions; Volpara Live, which provides radiographers instant patient-based image quality feedback; Volpara Lung, a patient management software; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses Tyrer-Cuzick v8 Risk Evaluation Tool to calculate patients' risk of developing breast cancer; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. Volpara Health Technologies Limited has a strategic relationship with RevealDx to enhance lung screening capabilities. The company was formerly known as Matakina Technology Ltd. and changed its name to Volpara Health Technologies Limited in October 2015. Volpara Health Technologies Limited was incorporated in 2009 and is headquartered in Wellington, New Zealand.
Volpara Health Technologiesと類似のipo年
- The Toronto-Dominion Bank PFD SER 9 3.7%のIPO年は2015です。
- Fura GemsのIPO年は2015です。
- Hostess BrandsのIPO年は2015です。
- Nabriva Therapeutics PlcのIPO年は2015です。
- REFのIPO年は2015です。
- H-SourceのIPO年は2015です。
- Volpara Health TechnologiesのIPO年は2016です。
- American Pacific BoratesのIPO年は2017です。
- RazerのIPO年は2017です。
- DEAG Deutsche Entertainment AktiengesellschaftのIPO年は2017です。
- Hamilton Beach Brands CoのIPO年は2017です。
- Artelo BiosciencesのIPO年は2017です。
- VARTA AGのIPO年は2017です。